Predictive Biosciences, a Lexington, Mass.-based developer of biomarker and assay technology for cancer diagnostics, has raised $10 million in Series A funding co-led by Highland Capital Partners and IDG Ventures Boston. www.predictivebiosci.com
Predictive Biosciences, a Lexington, Mass.-based developer of biomarker and assay technology for cancer diagnostics, has raised $10 million in Series A funding co-led by Highland Capital Partners and IDG Ventures Boston. www.predictivebiosci.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: